View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Carole Braudeau
  • Carole Braudeau

Credit Morning 03/06/2024

Cellnex: new guidance, agreement to sell Irish operations and IG rating at S&PGrifols A: Moody’s places Grifols’ B2 corporate rating on review for downgrade>...

Carole Braudeau
  • Carole Braudeau

Morning Crédit 06/03/2024

Cellnex : nouvelle guidance, accord de vente de Cellnex Irlande et obtention d’un rating IG chez S&PGrifols A : Moody’s place le rating corporate B2 de Grifols sous surveillance en vue d’une dégradation>...

Fresenius Medical Care AG: 1 director

A director at Fresenius Medical Care AG bought 15,823 shares at 38.632USD and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ...

Luis de Toledo Heras
  • Luis de Toledo Heras

ODDO BHF SECURITIES MORNING NEWS – DETAILED COMMENTS 02/20/2024

Campari shares are starting to show signs of flagging against the backdrop of a weaker-than-expected Q3 2023, a controversial acquisition in cognac, and dilution following the January capital increase. In addition, as the group diversifies, its profile increasingly resembles that of a pure player such as Pernod Ricard and Diageo, for which long-term growth and valuation levels are lower. By revising down our long-term growth estimates for Campari, we are lowering our target price to €...

Luis de Toledo Heras
  • Luis de Toledo Heras

ODDO BHF SECURITIES MORNING NEWS – COMMENTAIRES DETAILLES 20/02/2024

Le titre Campari commence à montrer des signes de faiblesses sur fond d’un T3 23 inférieur aux attentes, d’une acquisition controversée dans le cognac, et de la dilution suite à l’augmentation de capital de janvier. En outre, à mesure que le groupe se diversifie, son profil s’apparente à celui d’un pure player comme Pernod Ricard et Diageo, dont les niveaux de croissance de long terme et de valorisation sont inférieurs. En réduisant la croissance de long terme du groupe italien, nous ...

Carole Braudeau
  • Carole Braudeau

Morning Crédit 20/02/2024

Arcelor Mittal : le gouvernement italien met sous tutelle l'aciérie ex-Ilva>...

Oliver Metzger
  • Oliver Metzger

Fresenius Medical Care : Q4 review – Looking with confidence into 2024

>Q4 review – Ahead of expectations - Fresenius Medical Care's Q4 2023 revenues of € 4,988m (-0.1% y-o-y, 1% ahead of ODDO BHF/consensus) were supported by organic growth of 3.3% at the group level compared to our forecast of 4.3% and to consensus’ expectations of 5.5%. Acquisitions accounted for 410bp and forex created a headwind of 7.6%.Q4 adjusted EBIT of € 555m (+12.1% y-o-y, margin of 11.1%) was in line with our forecast and 2% ahead of the consensus. Reporte...

Oliver Metzger
  • Oliver Metzger

Fresenius Medical Care : On track for 2025 targets – incorporating hig...

>Q4 preview – strong finish of a better-than-expected year - Q4 revenues of € 4,930m (-1.3% y-o-y) should profit from organic growth of 4.3%, but suffer from divestments of 70bp and forex headwind of 490bp. We forecast revenues of € 3,897m (-2.4% y-o-y) for Care delivery impacted by the exit of some international markets. For Care enablement, we predict revenues of € 1,399m (+0.5% y-o-y) supported by organic growth of 5.3%. Q4 EBIT is expected to reach a strong ...

Ahmed Ben Salem ... (+6)
  • Ahmed Ben Salem
  • Bruno Cavalier
  • Marc Lavaud
  • Martin Marandon-Carlhian
  • Stephane Houri
  • Thomas Zlowodzki

ODDO BHF SECURITIES MORNING NEWS – COMMENTAIRES DETAILLES 05/02/2024

3 valeurs sortent aujourd’hui de notre liste de Convictions Large Caps européennes. Nous prenons nos profits sur ASML (+ 30% depuis son entrée dans la liste) après sa forte hausse post publication de son T4 2023. Inversement, nous coupons notre position sur RWE (-15% depuis son entrée) après de bons résultats 2023 mais une guidance 2024 revue en baisse. Nous conservons Sodexo dans son nouveau périmètre mais sortons Pluxee. - ...

Ahmed Ben Salem ... (+6)
  • Ahmed Ben Salem
  • Bruno Cavalier
  • Marc Lavaud
  • Martin Marandon-Carlhian
  • Stephane Houri
  • Thomas Zlowodzki

ODDO BHF SECURITIES MORNING NEWS – DETAILED COMMENTS 02/05/2024

We are removing three stocks from the ODDO BHF European Large Caps Convictions List today. We are taking our profits on ASML (+30% since its inclusion in the list) after its strong gains since the publication of its Q4 2023 results. Conversely, we are reducing our position on RWE (-15% since its inclusion in the list) following a good set of 2023 results but a downward revision to 2024 guidance. We maintain Sodexo in its new scope in the list but withdraw Pluxee - ...

Carole Braudeau
  • Carole Braudeau

Verallia : Credit feedback – ODDO BHF Forum, 11 to 16 January 2024

The 27th ODDO BHF forum was held in the form of physical meetings (11-12 January) and digital meetings (15-16 January). It was attended by 325 companies (compared with 322 in 2023 and 314 in 2022): ~40% French, 30% German and 30% from the rest of the EU (except one from US). - Our 2024 Forum welcomed 910 investors (vs. 781 in 2023) 53% of whom were French (vs. 58% in 2023) working for 378 institutions in 20 countries. We organised the equivalent of 8,196 investor meetings (vs. 7,...

Carole Braudeau
  • Carole Braudeau

Verallia : Feedback Crédit Forum du 11 au 16 janvier 2024

Notre 27ième Forum vient de se dérouler de manière présentielle (11-12 janvier), à Lyon, et en digital (les 15-16 janvier). Il a réuni 325 sociétés (vs 322 sociétés en 2023 et 314 en 2022), originaire à ~40% de France, à 30% d’Allemagne et les 30% restant venant du reste de l’Europe (sauf une société américaine). - L’édition 2024 de notre Forum a accueilli 910 investisseurs (781 en 2023) dont 53% français (vs 58% en 2023) travaillant pour 378 institutions de 20 pays. Nous avons ai...

Carole Braudeau
  • Carole Braudeau

Credit Morning 01/09/2024

Gotham City Research releases a report estimating that Grifols artificially reduces its leverage Reuters says Douglas plans for IPO in CQ1 24Tier 2 callable 2024 – calls continue to be exercised/managed (e.g. Piraeus) AT1 – KBC to repay its AT1 03/24 - Strong probability of AT1 call exercise for H1 2024>...

Carole Braudeau
  • Carole Braudeau

Morning Crédit 09/01/2024

Gotham City Research publie un rapport estimant que Grifols réduit artificiellement son levier Reuters says Douglas plans for IPO in CQ1 24Tier 2 callable 2024 – les calls continuent d’être exercés / gérés (ex. Piraeus) AT1 – KBC annonce le call – les proba de call des AT1 2024 sont fortes pour le S1>...

Carole Braudeau
  • Carole Braudeau

Credit Morning 12/07/2023

Iliad issues € 650m of new unsecured notes 5.375% 2029 and launches a tender offer on the 2024 bonds>...

Carole Braudeau
  • Carole Braudeau

Morning Crédit 07/12/2023

Iliad émet 650 m EUR de nouvelles obligations 5,375% 2029 et lance un tender sur les souches 2024>...

Carole Braudeau
  • Carole Braudeau

Credit Morning 12/01/2023

Auchan and Intermarché have submitted a joint offer for all of Casino's hypermarkets and supermarkets. Lufthansa will not open up the capital of Lufthansa Technik and is making an official request to the European Commission to invest in ITA Airways.>...

Carole Braudeau
  • Carole Braudeau

Morning Crédit 01/12/2023

Auchan et Intermarché ont déposé une offre conjointe sur l’intégralité des hypermarchés et supermarchés de Casino.Lufthansa n’ouvrira pas le capital de Lufthansa Technik et lance une demande officielle auprès de la Commission Européenne pour investir dans ITA Airways>...

Carole Braudeau
  • Carole Braudeau

Morning Crédit 27/11/2023

Casino : de nouvelles cessions de magasins à l’étude + cession de la participation de GPA dans Cnova à Casino Schaeffler increases offer price to EUR 94 per share for Vitesco>...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch